NCT04666922View on ClinicalTrials.gov

A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 765080

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 14, 2021

Primary Completion Date

August 25, 2021

Study Completion Date

August 25, 2021

Conditions
Healthy
Interventions
DRUG

BI 765080

BI 765080

DRUG

Placebo

Placebo; 0.9% saline for injection

Trial Locations (1)

2650

SGS Life Science Services - Clinical Research, Edegem

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04666922 - A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 765080 | Biotech Hunter | Biotech Hunter